Pangu
Contact
Clinical Trials
Patients

Skip to content

Company
Our Science
R&D
Patients
Careers
- Working at aTyr
- Career Opportunities
Investors and Media

© 2007 - 2024 aTyr Pharma. Legal Privacy Policy

ATYR1923 Modulates the Inflammatory Response in Experimental Models of Interstitial Lung Disease

American Thoracic Society, 2019

« The N-terminal domain of HARS is a novel NRP2 ligand and can regulate NRP2-dependent macrophage function

Domain-Specific Antibodies to Neuropilin 2 Implicate VEGF-C and not Semaphorin 3F in Breast Cancer Stem Cell Function »

© 2007 - 2024 aTyr Pharma. Legal Privacy Policy

By continuing to browse this site, you agree to our use of cookies.

MENU

Company
Our Science
R&D
Patients
Careers
- Career Opportunities
- Working at aTyr
Investors and Media
Privacy Policy